Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains. | Comput Biol Chem | 2022 | 35537364 | PubTator, text mining | PubMed |
| Sulfated β-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis. | Antiviral Res | 2022 | 35533778 | PubTator, text mining | PubMed |
| Phytomedicines explored under in vitro and in silico studies against coronavirus: An opportunity to develop traditional medicines. | S Afr J Bot | 2022 | 35530267 | PubTator, text mining | PubMed |
| Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for COVID-19 patients. | Beni Suef Univ J Basic Appl Sci | 2022 | 35529527 | PubTator, text mining | PubMed |
| Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants. | Biosaf Health | 2022 | 35528630 | PubTator, text mining | PubMed |
| Recognition of Immune Cell Markers of COVID-19 Severity with Machine Learning Methods. | Biomed Res Int | 2022 | 35528178 | PubTator, text mining | PubMed |
| Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine. | J Clin Lab Anal | 2022 | 35527696 | PubTator, text mining | PubMed |
| Intrinsic features of Zika Virus non-structural proteins NS2A and NS4A in the regulation of viral replication. | PLoS Negl Trop Dis | 2022 | 35522620 | PubTator, text mining | PubMed |
| The Potential of Eukaryotic Cell-Free Systems as a Rapid Response to Novel Zoonotic Pathogens: Analysis of SARS-CoV-2 Viral Proteins. | Front Bioeng Biotechnol | 2022 | 35519622 | PubTator, text mining | PubMed |
| Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022. | Emerg Infect Dis | 2022 | 35514025 | PubTator, text mining | PubMed |
| Evaluation of CRISPR-Based Assays for Rapid Detection of SARS-CoV-2: A Systematic Review and Meta-Analysis. | Yonsei Med J | 2022 | 35512751 | PubTator, text mining | PubMed |
| Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. | Gastroenterology | 2022 | 35508284 | PubTator, text mining | PubMed |
| Multifaceted role of natural sources for COVID-19 pandemic as marine drugs. | Environ Sci Pollut Res Int | 2022 | 35507224 | PubTator, text mining | PubMed |
| The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy. | J Biomed Sci | 2022 | 35505345 | PubTator, text mining | PubMed |
| Beneath the surface: Amino acid variation underlying two decades of dengue virus antigenic dynamics in Bangkok, Thailand. | PLoS Pathog | 2022 | 35500035 | PubTator, text mining | PubMed |
| Experimental and natural infections of severe acute respiratory syndrome-related coronavirus 2 in pets and wild and farm animals. | Vet World | 2022 | 35497948 | PubTator, text mining | PubMed |
| The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection. | Front Physiol | 2022 | 35492595 | PubTator, text mining | PubMed |
| Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19. | Front Physiol | 2022 | 35492581 | PubTator, text mining | PubMed |
| Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication. | iScience | 2022 | 35492218 | PubTator, text mining | PubMed |
Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages. | mSphere | 2022 | 35491827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=55